UK Markets closed

Global Drug Discovery Informatics Market Insights (2021 to 2026) - Key Analysis and Forecasts

·7-min read

Dublin, Dec. 20, 2021 (GLOBE NEWSWIRE) -- The "Drug Discovery Informatics Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product Type" report has been added to ResearchAndMarkets.com's offering.

This report describes the global market size of Drug Discovery Informatics from 2016 to 2020 and its CAGR from 2016 to 2020, and also forecasts its market size to the end of 2026 and its CAGR from 2021 to 2026.

For the geography segment, regional supply, demand, major players, price is presented from 2016 to 2026.

This report covers the following regions:

  • North America

  • South America

  • Asia & Pacific

  • Europe

  • MEA

The key countries for each region are also included such as the United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For the competitor segment, the report includes global key players of Drug Discovery Informatics as well as some small players.

The information for each competitor includes:

  • Company Profile

  • Business Information

  • SWOT Analysis

  • Revenue, Gross Margin and Market Share

Applications Segment:

  • Pharmaceutical & Biotechnology Companies

  • Contract Research Organizations (CROs)

  • Others

Types Segment:

  • Software

  • Services

Companies Covered:

  • Infosys

  • Thermo Fisher Scientific

  • Perkinelmer

  • Schrdinger

  • Dassault Systemes

  • Charles River Laboratories

  • Selvita

  • Certara

  • GVK Biosciences

  • Collaborative Drug Discovery

  • Openeye Scientific Software

Key Topics Covered:

Chapter 1 Executive Summary

Chapter 2 Abbreviation and Acronyms

Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method

4. Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users

Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 Covid-19 Impact

Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Drug Discovery Informatics Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users

Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics

Chapter 8 Historical and Forecast Drug Discovery Informatics Market in North America (2016-2026)
8.1 Drug Discovery Informatics Market Size
8.2 Drug Discovery Informatics Market by End Use
8.3 Competition by Players/Suppliers
8.4 Drug Discovery Informatics Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico

Chapter 9 Historical and Forecast Drug Discovery Informatics Market in South America (2016-2026)
9.1 Drug Discovery Informatics Market Size
9.2 Drug Discovery Informatics Market by End Use
9.3 Competition by Players/Suppliers
9.4 Drug Discovery Informatics Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru

Chapter 10 Historical and Forecast Drug Discovery Informatics Market in Asia & Pacific (2016-2026)
10.1 Drug Discovery Informatics Market Size
10.2 Drug Discovery Informatics Market by End Use
10.3 Competition by Players/Suppliers
10.4 Drug Discovery Informatics Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southest Asia
10.5.6 Australia

Chapter 11 Historical and Forecast Drug Discovery Informatics Market in Europe (2016-2026)
11.1 Drug Discovery Informatics Market Size
11.2 Drug Discovery Informatics Market by End Use
11.3 Competition by Players/Suppliers
11.4 Drug Discovery Informatics Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia

Chapter 12 Historical and Forecast Drug Discovery Informatics Market in MEA (2016-2026)
12.1 Drug Discovery Informatics Market Size
12.2 Drug Discovery Informatics Market by End Use
12.3 Competition by Players/Suppliers
12.4 Drug Discovery Informatics Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey

Chapter 13 Summary For Global Drug Discovery Informatics Market (2016-2021)
13.1 Drug Discovery Informatics Market Size
13.2 Drug Discovery Informatics Market by End Use
13.3 Competition by Players/Suppliers
13.4 Drug Discovery Informatics Market Size by Type

Chapter 14 Global Drug Discovery Informatics Market Forecast (2021-2026)
14.1 Drug Discovery Informatics Market Size Forecast
14.2 Drug Discovery Informatics Application Forecast
14.3 Competition by Players/Suppliers
14.4 Drug Discovery Informatics Type Forecast

Chapter 15 Analysis of Global Key Vendors
15.1 Infosys
15.1.1 Company Profile
15.1.2 Main Business and Drug Discovery Informatics Information
15.1.3 SWOT Analysis of Infosys
15.1.4 Infosys Drug Discovery Informatics Revenue, Gross Margin and Market Share (2016-2021)
15.2 Thermo Fisher Scientific
15.2.1 Company Profile
15.2.2 Main Business and Drug Discovery Informatics Information
15.2.3 SWOT Analysis of Thermo Fisher Scientific
15.2.4 Thermo Fisher Scientific Drug Discovery Informatics Revenue, Gross Margin and Market Share (2016-2021)
15.3 Perkinelmer
15.3.1 Company Profile
15.3.2 Main Business and Drug Discovery Informatics Information
15.3.3 SWOT Analysis of Perkinelmer
15.3.4 Perkinelmer Drug Discovery Informatics Revenue, Gross Margin and Market Share (2016-2021)
15.4 Schrodinger
15.4.1 Company Profile
15.4.2 Main Business and Drug Discovery Informatics Information
15.4.3 SWOT Analysis of Schrodinger
15.4.4 Schrodinger Drug Discovery Informatics Revenue, Gross Margin and Market Share (2016-2021)
15.5 Dassault Systemes
15.5.1 Company Profile
15.5.2 Main Business and Drug Discovery Informatics Information
15.5.3 SWOT Analysis of Dassault Systemes
15.5.4 Dassault Systemes Drug Discovery Informatics Revenue, Gross Margin and Market Share (2016-2021)
15.6 Charles River Laboratories
15.6.1 Company Profile
15.6.2 Main Business and Drug Discovery Informatics Information
15.6.3 SWOT Analysis of Charles River Laboratories
15.6.4 Charles River Laboratories Drug Discovery Informatics Revenue, Gross Margin and Market Share (2016-2021)
15.7 Selvita
15.7.1 Company Profile
15.7.2 Main Business and Drug Discovery Informatics Information
15.7.3 SWOT Analysis of Selvita
15.7.4 Selvita Drug Discovery Informatics Revenue, Gross Margin and Market Share (2016-2021)
15.8 Certara
15.8.1 Company Profile
15.8.2 Main Business and Drug Discovery Informatics Information
15.8.3 SWOT Analysis of Certara
15.8.4 Certara Drug Discovery Informatics Revenue, Gross Margin and Market Share (2016-2021)
15.9 GVK Biosciences
15.9.1 Company Profile
15.9.2 Main Business and Drug Discovery Informatics Information
15.9.3 SWOT Analysis of GVK Biosciences
15.9.4 GVK Biosciences Drug Discovery Informatics Revenue, Gross Margin and Market Share (2016-2021)
15.10 Collaborative Drug Discovery
15.10.1 Company Profile
15.10.2 Main Business and Drug Discovery Informatics Information
15.10.3 SWOT Analysis of Collaborative Drug Discovery
15.10.4 Collaborative Drug Discovery Drug Discovery Informatics Revenue, Gross Margin and Market Share (2016-2021)
15.11 Openeye Scientific Software
15.11.1 Company Profile
15.11.2 Main Business and Drug Discovery Informatics Information
15.11.3 SWOT Analysis of Openeye Scientific Software
15.11.4 Openeye Scientific Software Drug Discovery Informatics Revenue, Gross Margin and Market Share (2016-2021)

For more information about this report visit https://www.researchandmarkets.com/r/9lmkrb

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting